Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 162.3K |
Gross Profit | -162.3K |
Operating Expense | 3,945.0K |
Operating I/L | -3,945.0K |
Other Income/Expense | 78.8K |
Interest Income | 114.4K |
Pretax | -3,866.2K |
Income Tax Expense | 0.0K |
Net Income/Loss | -3,866.2K |
Pasithea Therapeutics Corp. is a biotechnology company specializing in the research and development of treatments for psychiatric and neurological disorders. The company's revenue streams are derived from the operation of anti-depression clinics and the provision of business support services, which involve trained pharmacists administering intravenous infusions of ketamine. These services cater to individuals seeking alternative treatments for depression and related conditions, positioning the company at the forefront of mental health innovation.